Archer Materials is making strides in advancing its Biochip technology, focusing on improving the accuracy of graphene field effect transistor sensors for blood potassium testing, crucial for chronic ...
Archer Materials Limited (“Archer”, the “Company”), a semiconductor company advancing the quantum computing and medical diagnostics industries, has developed a next generation biochip fabrication to ...
A new “biochip” under development to accurately identify disease strains may reduce costs for medical testing and also reduce wait time for results. The Hydra-1K — which is a silicon chip — can be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback